Navigation Links
LXQ High Throughput Linear Ion Trap from Thermo Scientific

ProductsLXQ High Throughput Linear Ion Trap from Thermo Scientific
Company Thermo Scientific
Item LXQ High Throughput Linear Ion Trap
Price 
Description The LXQ linear ion trap mass spectrometer enables high-throughput solutions for todays fast paced analytical laboratory.

The LXQ linear ion trap mass spectrometer is designed for drug discovery and proteomic applications, delivering the fast cycle time and increased sensitivity of a Thermo linear ion trap at an attractive price. The combination of fast cycle time and high MS n spectral quality results in rapid and reliable compound detection and structural identification to accelerate screening for drugs, their metabolites, and degradation products.

LXQ High sensitivity for todays analytical laboratory

  • High-throughput linear ion trap
  • Confident structural identification
  • Rapid reliable analysis
  • High-quality MSn characterization
  • Advanced Data DependentTM suite facilitates automated analysis of unknown samples
Applications include:
  • Metabolite identification
  • Metabolic stability determination
  • Simultaneous forensics identification and quantification
  • Protein and PTM identification
Info Thermo ScientificThermo Scientific
355 River Oaks Parkway
San Jose, CA 95134-1991
Customer Service: 1- 408-965-6000
Fax: 1-408-965-6010
Web Site: http://www.thermo.com

For chromatography columns contact:
Thermo Scientific
320 Rolling Ridge Drive
Bellefonte, PA 16823

Call Thermo Scientific to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-563-2486
Customer Service: 1-800-532-4752
Fax Number: 1-814-353-2305
Web Site: http://www.thermo.com/chromatography
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Catch & Release v2.0 High Throughput (HT) Immunoprecipitation Assay Kit- 96 well from Upstate
2. Biomek FX Laboratory Workstation (High Throughput) from Beckman Coulter
3. High-Throughput Fluidics System from Bio-Rad
4. Biomek FX Laboratory Workstation (High Throughput) from Beckman Coulter
5. E-Gel96 High-Throughput Agarose Electrophoresis System from Invitrogen
6. LTQ XL Linear Ion Trap from Thermo Scientific
7. RTS AviTag E. coli Biotinylation Kit, Linear Template; Linear template generation and in vitro protein mono-biotinylation system for use with RTS 100 expression reactions from Roche Applied Science
8. AXIMA-LNR Linear MALDI TOF from Shimadzu Biotech
9. Voice Coil Linear Scanning System from Physik Instrumente
10. LTQ XL Linear Ion Trap from Thermo Scientific
11. XRS Series Precision Linear Tables from Parker Hannifin Corporation
Mouse Anti-Human huntingtin Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
PureLink HiPure Plasmid Filter Midiprep Kit from Invitrogen
ViraPower UbC Lentiviral Gateway Expression Kit from Invitrogen
ViraPower Lentiviral Packaging Mix from Invitrogen
Biology Products:
(Date:11/6/2009)...open for the Society of Interventional Radiology,s...ies" Webinar, which will provide the latest update...iver tumors, kidney tumor ablation and lung tumor ...ians, scientists and allied health professionals d...ring advances in image-guided therapy. , The Web...
(Date:11/6/2009)... -- Auburn Hills, MI-based Law Enforcement Intelli...cker system and patent-pending Biometric Access Co...Health and Human Services, National Institutes of ...stem will support the NIH,s entire police force th...cal research agency. The project is expected to b...
(Date:11/5/2009)...ale University have developed synthetic molecules ... HIV and HIV-infected cells, as well as to prostat...n the Journal of the American Chemical Society , ...se diseases. , The molecules called "antibody-...tibody-recruiting molecule targeting prostate canc...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 1Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 2Discovery of natural odors could help develop mosquito repellents 13710 1Discovery of natural odors could help develop mosquito repellents 13710 2Discovery of natural odors could help develop mosquito repellents 13710 3Senator Ted Kennedy 3A A Member of the NAMI Family 55466 1Senator Ted Kennedy 3A A Member of the NAMI Family 55466 2
...ly reside on the skin of healthy people can cause ... researchers at the Swedish medical university Kar...or why a certain kind of staphylococcus can attach...osystems: the bacteria are like tufted, self-adhes...elf on the child,s skin and mucous membranes direc...
... limestone countertop, a practiced eye and Google ... of fossils that may shed light on the origins of ...ous story, featuring University of Michigan paleon... Sanders, is the subject of a segment on the award...ently airing on public television stations (Episod...
...y Sanders today joined UC San Diego Chancellor Mar... to announce their support for a regional partners...gae into biofuels. , Speaking at a news conferenc...hers said the San Diego region, now home to more t...jor center for renewable energy development, as sc...
Other Biology News:Tufted bacteria cause infection in premature babies 2Google Earth aids discovery of early African mammal fossils 2Google Earth aids discovery of early African mammal fossils 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 4Regional partnership to develop algal biofuels gets backing of San Diego leaders 5Regional partnership to develop algal biofuels gets backing of San Diego leaders 6
(Date:11/6/2009)...IENNA, Austria, November 6 EUCODIS...nufacturing, and marketing enzymes for the,chemica...o a research,agreement with Bio Sidus, the leading..., The agreement gives EUCODIS Bioscience exclu...t - to Bio Sidus, proprietary collection of,psychr...
(Date:11/6/2009)...RD, Calif., Nov. 6 Intarcia Therap...its ITCA 650 (DUROS® continuous delivery of e...etes at the Ninth Annual Diabetes Technology Meeti...newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...e Via ITCA 650 Lowers Plasma Glucose, HbA1c and Re...
(Date:11/5/2009)...NGTON, Colo., Nov. 5 The endangere...n the western U.S. This rare carnivore feeds on p...le to plague and often entire population die-offs ...ice (FWS) has implemented a ferret breeding progra...into their formerly native habitat. Unfortunately...
(Date:11/5/2009)...rence Call on Thursday, November 5, 2009 at 4:30 p...Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmace...AQ: OGXI ) today reported unaudited financial res...eptember 30, 2009 and reviewed the Company,s highl...lowing consolidated results reflect the operations...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8